Sonoma Biotherapeutics

Sonoma Biotherapeutics

Biotechnology Research

South San Francisco, California 13,769 followers

Leading the Next Frontier of Cell Therapy

About us

Sonoma Biotherapeutics is developing engineered regulatory T cell (Treg) therapies to treat serious autoimmune and inflammatory diseases driven by an imbalanced immune system. Founded by pioneers in Treg biology and cell therapy, the company is employing proprietary platform technologies and approaches to develop a new generation of targeted Treg cell therapies designed to induce durable immune tolerance to treat and prevent autoimmune and inflammatory diseases. Sonoma Biotherapeutics is based in South San Francisco and Seattle.

Website
https://www.sonomabio.com
Industry
Biotechnology Research
Company size
51-200 employees
Headquarters
South San Francisco, California
Type
Privately Held

Locations

Employees at Sonoma Biotherapeutics

Updates

Similar pages

Browse jobs

Funding

Sonoma Biotherapeutics 4 total rounds

Last Round

Corporate round

US$ 30.0M

Investors

Regeneron
See more info on crunchbase